Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
NCT01560169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2013-10-10
Summary
This is an evaluation of celiac-specific patient reported outcome instruments in celiac disease patients.
Conditions
Sponsors & Collaborators
-
Alvine Pharmaceuticals Inc.
lead INDUSTRY
Principal Investigators
-
Daniel Adelman, MD · Alvine Pharmaceuticals Inc.
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Prospective Study of Undiagnosed Celiac Disease
NCT01317914 ·Status: COMPLETED ·Phase: NA
-
Evidence-based Screening Strategies for Celiac Disease
NCT03136731 ·Status: ENROLLING_BY_INVITATION
-
Can a Very High Result From a Screening Test for Celiac Disease be Used to Diagnose Celiac Disease?
NCT00175760 ·Status: COMPLETED
-
Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal
NCT00669825 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
NCT03409796 ·Status: COMPLETED ·Phase: NA
-
Study of the NATURal History, Epidemiological, Clinical, Diagnostic and Therapeutic Aspects of CELiac Disease and Non-celiac Enteropathies
NCT07070596 ·Status: RECRUITING
-
Treatment of Screen-detected Celiac Disease
NCT01116505 ·Status: COMPLETED ·Phase: NA
-
Mass Screening for the Early Detection of Patients With Celiac Disease.
NCT05186038 ·Status: COMPLETED
-
A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease
NCT03521180 ·Status: COMPLETED
-
Serum Markers in Gluten Challenge
NCT00931892 ·Status: COMPLETED ·Phase: NA
-
Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]
NCT03011931 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Gluten Technology and Education for Celiac Health
NCT06059716 ·Status: RECRUITING ·Phase: NA
-
Assessment of Coeliac Disease in Patients With Type 2 Diabetes
NCT06283264 ·Status: NOT_YET_RECRUITING
-
Detection of Immunotoxic Gluten Peptides in Feces
NCT01478867 ·Status: COMPLETED
-
Background of Different Phenotypes of Coeliac Disease
NCT05597904 ·Status: RECRUITING
-
Screen-detected Coeliac Disease, a Population Based Study
NCT01695681 ·Status: COMPLETED ·Phase: NA
-
Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease
NCT06324539 ·Status: RECRUITING
-
Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease
NCT00250146 ·Status: TERMINATED ·Phase: NA
-
Virtual Celiac Symptoms Study in Adults and Teenagers
NCT05309330 ·Status: COMPLETED
-
Use of a Home Test for Gluten Detection in Urine and Its Effect on Gluten-free Diet Adherence
NCT05119322 ·Status: SUSPENDED ·Phase: NA
-
Symptomatic Response to Gluten Challenge in Patients With Suspected Non Celiac Gluten Sensitivity
NCT01864993 ·Status: COMPLETED ·Phase: NA
-
Immune Responses to Gluten
NCT05209568 ·Status: RECRUITING ·Phase: NA
-
Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Patients With Non-coeliac Gluten Sensitivity
NCT03798249 ·Status: UNKNOWN ·Phase: NA
-
Immune Response in Celiac Disease on In-vitro Gluten Challenge
NCT01909050 ·Status: COMPLETED
-
Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Healthy Subjects
NCT03798262 ·Status: COMPLETED ·Phase: NA